Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.76277 | 32 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.74636 | 33 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.74919 | 33 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.71554 | 34 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.70267 | 33 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.84115 | 34 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.79202 | 33 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.72451 | 32 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.7111 | 32 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.74397 | 33 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.73052 | 33 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.7265 | 33 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.7423 | 33 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.73584 | 33 |